必瘦站(01830.HK)指其「醫療+美容」中心合同銷售達4,480萬
必瘦站(01830.HK)公布,香港首間專科痛症醫療暨醫學美容服務中心自去年11月30日起,採用「醫療+美容」運營模式下首六十營業日,合同銷售達破紀錄金額至4,480萬元,並成為集團「全球最高銷售」之分店。
該分店之每名顧客平均消費對比香港其他分店大幅增加23.1%。展望將來,「醫療+美容」運營模式可發揮系內生態圈的協同效益並同步提升客戶長期粘性及終身價值。
鑒於首間採用「醫療+美容」運營模式的服務中心取得驕人成績,集團將複製此「醫療+美容」的成功運營模式至集團香港所有服務中心,亦積極探討複製「醫療+美容」運營模式至中國內地、澳洲及新加坡的可行性。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.